Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Corkscrew device retrieves clots, quickly reverses stroke damage

06.02.2004


American Stroke Association meeting report



A revolutionary tiny corkscrew that captures blood clots from vessels deep inside the brain can "almost instantly" reverse damage caused by ischemic stroke, according to the first report on the safety and efficacy of the device presented today at the American Stroke Association’s 29th International Stroke Conference.

Ischemic strokes are caused by a blood clot that blocks blood supply to the brain. Each year, about 700,000 Americans suffer a stroke and 88 percent of those strokes are ischemic, according to the American Stroke Association.


Blood clots causing stroke can be dissolved using the FDA-approved clot-busting drug tissue plasminogen activator (tPA) as standard therapy. But, it must be initiated intravenously within three hours (the earlier the better) of stroke onset to be effective.

Moreover, it "typically takes one to two hours for tPA to dissolve a clot and open a vessel, if at all," said Sidney Starkman, M.D., professor of emergency medicine and neurology at the University of California, Los Angeles and co-director of the UCLA Stroke Center.

The investigational device, the Concentric MERCI® Retrieval System, restored blood flow in 61 of 114 patients (54 percent) in Phase I and II of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI I /II) trials, which studied patients up to eight hours after initial stroke symptoms who were not eligible for standard tPA therapy, said principal investigator Starkman.

Restoring blood flow in these trials reversed paralysis and other stroke symptoms, Starkman said.

"How often do we get a chance to reverse a patient’s stroke on the table? We have had patients completely paralyzed on one side of their body, who were made normal almost instantaneously when the clot was retrieved," he said.

Of the 61 patients whose arteries were unblocked with the device, "23 have no disability or have minor disability, such as hand writing problems," Starkman said.

The MERCI® Retrieval System is inserted into an artery in the groin, and then carefully guided via standard angiography into the brain until it reaches the blood clots. The device is made from a combination of nickel and titanium, "which is unique in that it allows the device to have a ’memory.’ So in this case, when it is deployed, it ’remembers’ to form itself into a helical shape, like a corkscrew," Starkman said.

Starkman says the corkscrew-shaped MERCI Retriever is the only device specifically designed to remove clots from all major cerebral vessels.

Once the device "captures" the blood clot, the device and clot are withdrawn into a larger catheter with a balloon. During the evacuation process, the balloon is briefly inflated to momentarily stop blood flow so the clots can be safely removed. Starkman added that the retrieval procedure can only be performed by a highly trained team at specialized centers.

The results presented today are based on 114 patients from 25 centers, (average age 70, 46 percent women), whose average National Institutes of Health baseline stroke score was 19, which indicates severe impairment.

"Thus far, we have seen that the MERCI® Retrieval System is quite safe and we believe it holds great promise, but more research is needed to refine the device and study its effectiveness," Starkman said.


Concentric Medical, Inc. of Mountain View, California funded the studies. The Food and Drug Administration is reviewing the device.

Carole Bullock | EurekAlert!
Further information:
http://www.americanheart.org/

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>